Annual EBITDA
-$92.74M$50.42M+35.22%
Summary
- Current Value
- As of today, ANAB annual EBITDA is -$92.74M, up +35.22% on
- Historical Performance
- ANAB annual EBITDA is down -70.94% over the past 3 years, and up +2.42% over the past 5 years
- All-Time High Comparison
- ANAB annual EBITDA is currently -1911.05% below its historical high of $5.12M set on
- 3-Year Low Comparison
- ANAB annual EBITDA is +35.22% above its 3-year low of -$143.16M reached on
- Sector Comparison
- ANAB annual EBITDA is higher than 18.76% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$92.74M | +35.2% | -70.9% | +2.4% | -2173.7% | |
| Quarterly EBITDA | $35.31M | +259.4% | +221.6% | +245.9% | +7895.6% | |
| TTM EBITDA | -$26.26M | +80.9% | +77.8% | +66.7% | -5696.3% | |
| Price | $48.13 | +229.2% | +82.4% | +101.5% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $91.28M | +432.0% | +44.5% | +1041.0% | +1564.8% | |
| Annual EPS | -$5.12 | +15.8% | -142.9% | -42.3% | -1737.3% | |
| -$95.14M | +34.6% | -68.8% | +1.4% | -1942.1% | ||
| Annual Net Income | -$145.23M | +11.2% | -151.3% | -49.2% | -2519.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$92.74M | at high | |
| 5Y | -$18.31M | N/A | -406.4% |
| All | $5.12M | -1911.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$143.16M | +35.2% | |
| 5Y | -$143.16M | +35.2% | |
| All | -$143.16M | +35.2% |
EBITDA History
FAQ
What is the current annual EBITDA of ANAB?
As of today, ANAB annual EBITDA is -$92.74M
What is 1-year change in ANAB annual EBITDA?
ANAB annual EBITDA is up +35.22% year-over-year
What is 3-year change in ANAB annual EBITDA?
ANAB annual EBITDA is down -70.94% over the past 3 years
How far is ANAB annual EBITDA from its all-time high?
ANAB annual EBITDA is currently -1911.05% below its historical high of $5.12M set on December 31, 2014
How does ANAB annual EBITDA rank versus sector peers?
ANAB annual EBITDA is higher than 18.76% of companies in Healthcare sector
When is ANAB next annual earnings release?
The next annual earnings release for ANAB is on
Quarterly EBITDA
$35.31M$60.88M+238.11%
Summary
- Current Value
- As of today, ANAB quarterly EBITDA is $35.31M, up +238.11% on
- Historical Performance
- ANAB quarterly EBITDA is up +259.35% year-over-year, and up +221.57% over the past 3 years
- All-Time High Comparison
- ANAB quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ANAB quarterly EBITDA is +180.61% above its 3-year low of -$43.81M reached on
- Sector Comparison
- ANAB quarterly EBITDA is higher than 84.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $35.31M | +238.1% | +259.4% | +221.6% | +245.9% | |
| Annual EBITDA | -$92.74M | – | +35.2% | -70.9% | +2.4% | |
| TTM EBITDA | -$26.26M | +68.6% | +80.9% | +77.8% | +66.7% | |
| Price | $48.13 | +48.3% | +229.2% | +82.4% | +101.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $76.32M | +242.8% | +154.3% | +5802.6% | +100.0% | |
| Quarterly EPS | $0.52 | +138.8% | +145.8% | +144.0% | +159.9% | |
| $34.70M | +232.6% | +252.5% | +217.1% | +242.6% | ||
| Quarterly Net Income | $15.11M | +139.1% | +146.0% | +145.1% | +163.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $35.31M | at high | |
| 3Y | $35.31M | at high | |
| 5Y | $35.31M | at high | |
| All | $35.31M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$26.93M | +231.1% | |
| 3Y | -$43.81M | +180.6% | |
| 5Y | -$43.81M | +180.6% | |
| All | -$43.81M | +180.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ANAB?
As of today, ANAB quarterly EBITDA is $35.31M
What is ANAB quarterly EBITDA most recent change?
ANAB quarterly EBITDA was up +238.11% on September 30, 2025
What is 1-year change in ANAB quarterly EBITDA?
ANAB quarterly EBITDA is up +259.35% year-over-year
How far is ANAB quarterly EBITDA from its all-time high?
ANAB quarterly EBITDA is currently at its all-time high
How does ANAB quarterly EBITDA rank versus sector peers?
ANAB quarterly EBITDA is higher than 84.00% of companies in Healthcare sector
When is ANAB next earnings release?
The next earnings release for ANAB is on
TTM EBITDA
-$26.26M$57.48M+68.64%
Summary
- Current Value
- As of today, ANAB TTM EBITDA is -$26.26M, up +68.64% on
- Historical Performance
- ANAB TTM EBITDA is up +80.93% year-over-year, and up +77.79% over the past 3 years
- All-Time High Comparison
- ANAB TTM EBITDA is currently -375.32% below its historical high of $9.54M set on
- 3-Year Low Comparison
- ANAB TTM EBITDA is +83.03% above its 3-year low of -$154.70M reached on
- Sector Comparison
- ANAB TTM EBITDA is higher than 41.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$26.26M | +68.6% | +80.9% | +77.8% | +66.7% | |
| Annual EBITDA | -$92.74M | – | +35.2% | -70.9% | +2.4% | |
| Quarterly EBITDA | $35.31M | +238.1% | +259.4% | +221.6% | +245.9% | |
| Price | $48.13 | +48.3% | +229.2% | +82.4% | +101.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $169.47M | +37.6% | +196.4% | +3674.3% | +841.5% | |
| TTM EPS | -$2.82 | +37.0% | +53.6% | +41.6% | -4.0% | |
| -$28.68M | +66.7% | +79.5% | +76.2% | +63.9% | ||
| TTM Net Income | -$84.63M | +36.2% | +48.9% | +37.2% | -14.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$26.26M | at high | |
| 3Y | -$26.26M | at high | |
| 5Y | $9.54M | -375.3% | |
| All | $9.54M | -375.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$112.55M | N/A | +76.7% |
| 3Y | -$154.70M | +83.0% | |
| 5Y | -$154.70M | +83.0% | |
| All | -$154.70M | +83.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ANAB?
As of today, ANAB TTM EBITDA is -$26.26M
What is ANAB TTM EBITDA most recent change?
ANAB TTM EBITDA was up +68.64% on September 30, 2025
What is 1-year change in ANAB TTM EBITDA?
ANAB TTM EBITDA is up +80.93% year-over-year
How far is ANAB TTM EBITDA from its all-time high?
ANAB TTM EBITDA is currently -375.32% below its historical high of $9.54M set on September 30, 2021
How does ANAB TTM EBITDA rank versus sector peers?
ANAB TTM EBITDA is higher than 41.41% of companies in Healthcare sector
When is ANAB next earnings release?
The next earnings release for ANAB is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ANAB Official Website www.anaptysbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1370053/000137005325000089/0001370053-25-000089-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1370053/000137005325000024/0001370053-25-000024-index.htm
- ANAB Profile on Yahoo Finance finance.yahoo.com/quote/ANAB
- ANAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anab